Redmile Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-916,927
| Closed | -$20.8M | – | 62 |
|
2016
Q3 | $20.8M | Sell |
916,927
-549,610
| -37% | -$12.5M | 1.66% | 23 |
|
2016
Q2 | $34.6M | Buy |
1,466,537
+576,930
| +65% | +$13.6M | 3.31% | 11 |
|
2016
Q1 | $18.1M | Sell |
889,607
-68,548
| -7% | -$1.4M | 1.86% | 21 |
|
2015
Q4 | $49.3M | Buy |
958,155
+188,514
| +24% | +$9.7M | 3.69% | 10 |
|
2015
Q3 | $32.8M | Buy |
769,641
+616,941
| +404% | +$26.3M | 2.49% | 18 |
|
2015
Q2 | $6.96M | Buy |
+152,700
| New | +$6.96M | 0.57% | 43 |
|
2014
Q2 | – | Sell |
-452,194
| Closed | -$11.7M | – | 62 |
|
2014
Q1 | $11.7M | Buy |
+452,194
| New | +$11.7M | 1.4% | 32 |
|